Industry
Medical - Instruments & Supplies
Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Insights
July 27, 2023 | 5:31 pm
Portfolio Pulse from Lisa Levin
July 27, 2023 | 4:53 pm
Portfolio Pulse from Vandana Singh
July 27, 2023 | 4:26 pm
Portfolio Pulse from Benzinga Newsdesk
July 27, 2023 | 2:27 pm
Portfolio Pulse from Happy Mohamed
July 27, 2023 | 2:20 pm
Portfolio Pulse from Happy Mohamed
July 27, 2023 | 2:17 pm
Portfolio Pulse from Benzinga Insights
July 27, 2023 | 1:06 pm
Portfolio Pulse from Happy Mohamed
July 27, 2023 | 12:46 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.